{"entry_id": "9a33ed10-04f2-4946-8b1e-27e66031ac37", "infos": [{"txt": "header", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 0, "bbox": [[0.758, 0.032, 0.904, 0.044]]}]}, "tags": ["header"], "label": "O", "web_segment_id": 1, "global_sentence_id": 0, "edu_l1_label": "EDU_O"}, {"txt": "header", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 0, "bbox": [[0.84, 0.052, 0.904, 0.063]]}]}, "tags": ["header"], "label": "O", "web_segment_id": 2, "global_sentence_id": 1, "edu_l1_label": "EDU_O"}, {"txt": "header", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 0, "bbox": [[0.101, 0.015, 0.428, 0.129]]}]}, "tags": ["header"], "label": "O", "web_segment_id": 3, "global_sentence_id": 2, "edu_l1_label": "EDU_O"}, {"txt": "header", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 0, "bbox": [[0.807, 0.071, 0.904, 0.085]]}]}, "tags": ["header"], "label": "O", "web_segment_id": 4, "global_sentence_id": 3, "edu_l1_label": "EDU_O"}, {"txt": "header", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 0, "bbox": [[0.862, 0.098, 0.904, 0.112]]}]}, "tags": ["header"], "label": "O", "web_segment_id": 5, "global_sentence_id": 4, "edu_l1_label": "EDU_O"}, {"txt": "行业研究", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 100000, "bbox": [[0.03, 0.093, 0.051, 0.168]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 6, "global_sentence_id": 5, "edu_l1_label": "EDU_O"}, {"txt": "医药", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 200000, "bbox": [[0.103, 0.149, 0.131, 0.16]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 7, "global_sentence_id": 6, "edu_l1_label": "EDU_O"}, {"txt": "太平洋医药日报（20250317):", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 300000, "bbox": [[0.104, 0.19, 0.494, 0.209]]}]}, "tags": ["title"], "label": "article_title", "web_segment_id": 8, "global_sentence_id": 7, "edu_l1_label": "BOT"}, {"txt": "Rytelo在欧盟获批上市", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 300000, "bbox": [[0.494, 0.19, 0.798, 0.209]]}]}, "tags": ["title"], "label": "article_title", "web_segment_id": 8, "global_sentence_id": 8, "edu_l1_label": "BOT"}, {"txt": "太平洋证券股份有限公司证券研究报告", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 400000, "bbox": [[0.03, 0.329, 0.051, 0.664]]}]}, "tags": ["title"], "label": "source", "web_segment_id": 9, "global_sentence_id": 9, "edu_l1_label": "EDU_O"}, {"txt": "走势比较", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 500000, "bbox": [[0.138, 0.248, 0.211, 0.261]]}]}, "tags": ["figure_caption"], "label": "figure_title", "web_segment_id": 10, "global_sentence_id": 10, "edu_l1_label": "EDU_O"}, {"txt": "figure", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 600000, "bbox": [[0.101, 0.28, 0.375, 0.422]]}]}, "tags": ["figure"], "label": "figure", "web_segment_id": 11, "global_sentence_id": 11, "edu_l1_label": "EDU_O"}, {"txt": "子行业评级", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 700000, "bbox": [[0.138, 0.442, 0.228, 0.454]]}]}, "tags": ["table_caption"], "label": "table_title", "web_segment_id": 12, "global_sentence_id": 12, "edu_l1_label": "EDU_O"}, {"txt": "table", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 800000, "bbox": [[0.097, 0.465, 0.378, 0.543]]}]}, "tags": ["table"], "label": "table", "web_segment_id": 13, "global_sentence_id": 13, "edu_l1_label": "EDU_O"}, {"txt": "☐   推荐公司及评级", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 800000, "bbox": [[0.103, 0.558, 0.114, 0.568], [0.139, 0.557, 0.258, 0.569]]}]}, "tags": ["text"], "label": "O", "web_segment_id": 14, "global_sentence_id": 14, "edu_l1_label": "EDU_O"}, {"txt": "相关研究报告", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 900000, "bbox": [[0.104, 0.643, 0.205, 0.655]]}]}, "tags": ["title"], "label": "reference", "web_segment_id": 15, "global_sentence_id": 15, "edu_l1_label": "EDU_O"}, {"txt": "《股票回购彰显长期发展信心，产能投放有望驱动收入快速增长＞>--2025-03-16", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1000000, "bbox": [[0.102, 0.674, 0.373, 0.685], [0.104, 0.69, 0.376, 0.696], [0.102, 0.708, 0.188, 0.717]]}]}, "tags": ["text"], "label": "reference", "web_segment_id": 16, "global_sentence_id": 16, "edu_l1_label": "EDU_O"}, {"txt": "《太平洋医药日报（20250314)：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1100000, "bbox": [[0.103, 0.725, 0.336, 0.735]]}]}, "tags": ["text"], "label": "reference", "web_segment_id": 17, "global_sentence_id": 17, "edu_l1_label": "EDU_O"}, {"txt": "罗氏伊那利塞片在华获批上市＞>--2025-03-15", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1100000, "bbox": [[0.336, 0.725, 0.372, 0.735], [0.104, 0.742, 0.376, 0.748], [0.102, 0.76, 0.144, 0.769]]}]}, "tags": ["text"], "label": "reference", "web_segment_id": 17, "global_sentence_id": 18, "edu_l1_label": "EDU_O"}, {"txt": "证券分析师：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1200000, "bbox": [[0.104, 0.795, 0.196, 0.806]]}]}, "tags": ["text"], "label": "author", "web_segment_id": 18, "global_sentence_id": 19, "edu_l1_label": "EDU_O"}, {"txt": "周豫", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1200000, "bbox": [[0.196, 0.795, 0.239, 0.806]]}]}, "tags": ["text"], "label": "author", "web_segment_id": 18, "global_sentence_id": 20, "edu_l1_label": "EDU_O"}, {"txt": "E-MAIL:", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1300000, "bbox": [[0.102, 0.812, 0.154, 0.82]]}]}, "tags": ["text"], "label": "author", "web_segment_id": 19, "global_sentence_id": 21, "edu_l1_label": "EDU_O"}, {"txt": "zhouyua@tpyzq.com", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1300000, "bbox": [[0.154, 0.812, 0.287, 0.82]]}]}, "tags": ["text"], "label": "author", "web_segment_id": 19, "global_sentence_id": 22, "edu_l1_label": "EDU_O"}, {"txt": "分析师登记编号：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1400000, "bbox": [[0.104, 0.826, 0.211, 0.836]]}]}, "tags": ["text"], "label": "author", "web_segment_id": 20, "global_sentence_id": 23, "edu_l1_label": "EDU_O"}, {"txt": "S1190523060002", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1400000, "bbox": [[0.211, 0.826, 0.322, 0.835]]}]}, "tags": ["text"], "label": "author", "web_segment_id": 20, "global_sentence_id": 24, "edu_l1_label": "EDU_O"}, {"txt": "证券分析师：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1500000, "bbox": [[0.104, 0.842, 0.196, 0.852]]}]}, "tags": ["text"], "label": "author", "web_segment_id": 21, "global_sentence_id": 25, "edu_l1_label": "EDU_O"}, {"txt": "张崴", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1500000, "bbox": [[0.196, 0.842, 0.24, 0.853]]}]}, "tags": ["text"], "label": "author", "web_segment_id": 21, "global_sentence_id": 26, "edu_l1_label": "EDU_O"}, {"txt": "E-MAIL:", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1600000, "bbox": [[0.102, 0.859, 0.154, 0.867]]}]}, "tags": ["text"], "label": "author", "web_segment_id": 22, "global_sentence_id": 27, "edu_l1_label": "EDU_O"}, {"txt": "zhangwei@tpyzq.com", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1600000, "bbox": [[0.154, 0.859, 0.294, 0.867]]}]}, "tags": ["text"], "label": "author", "web_segment_id": 22, "global_sentence_id": 28, "edu_l1_label": "EDU_O"}, {"txt": "报告摘要", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1700000, "bbox": [[0.402, 0.256, 0.501, 0.274]]}]}, "tags": ["title"], "label": "title1", "web_segment_id": 23, "global_sentence_id": 29, "edu_l1_label": "BOS"}, {"txt": "市场表现：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1800000, "bbox": [[0.438, 0.298, 0.509, 0.309]]}]}, "tags": ["title"], "label": "title2", "web_segment_id": 24, "global_sentence_id": 30, "edu_l1_label": "IOS"}, {"txt": "2025年3月17日，医药板块涨跌幅＋0.02%，跑赢沪深300指数0.26pct，涨跌幅居申万31个子行业第20名。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1900000, "bbox": [[0.436, 0.316, 0.917, 0.326], [0.403, 0.332, 0.729, 0.342]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 25, "global_sentence_id": 31, "edu_l1_label": "IOS"}, {"txt": "各医药子行业中，其他生物制品（+1.13%）、血液制品（+0.63%）、医疗耗材（+0.34%）表现居前，医院（-1.28%）、线下药店（-1.04%）、医疗设备（-0.53%）表现居后。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1900000, "bbox": [[0.729, 0.332, 0.916, 0.341], [0.405, 0.348, 0.916, 0.358], [0.405, 0.365, 0.861, 0.375]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 25, "global_sentence_id": 32, "edu_l1_label": "IOS"}, {"txt": "个股方面，日涨幅榜前3位分别为金城医药（+11.53%）、荣昌生物（+11.09%）、东方海洋（+10.17%)；", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1900000, "bbox": [[0.861, 0.365, 0.918, 0.375], [0.406, 0.382, 0.917, 0.392], [0.406, 0.397, 0.543, 0.408]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 25, "global_sentence_id": 33, "edu_l1_label": "IOS"}, {"txt": "跌幅榜前3位为赛隆药业（-9.98%）、普瑞眼科（-7.79%）、共同药业（-7.63%）。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 1900000, "bbox": [[0.543, 0.397, 0.918, 0.408], [0.403, 0.413, 0.615, 0.424]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 25, "global_sentence_id": 34, "edu_l1_label": "IOS"}, {"txt": "行业要闻：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2000000, "bbox": [[0.438, 0.445, 0.509, 0.456]]}]}, "tags": ["title"], "label": "title2", "web_segment_id": 26, "global_sentence_id": 35, "edu_l1_label": "IOS"}, {"txt": "近日，Geron宣布，欧盟委员会（EC）已批准其端粒酶抑制剂Rytelo （imetelstat）作为单药疗法，用于治疗因极低危、低危或中危骨髓增生异常综合征导致的输血依赖性贫血成人患者。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2100000, "bbox": [[0.438, 0.462, 0.918, 0.473], [0.412, 0.478, 0.916, 0.489], [0.406, 0.495, 0.722, 0.506]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 27, "global_sentence_id": 36, "edu_l1_label": "IOS"}, {"txt": "Rytelo是一款FIC寡核苷酸端粒酶抑制剂，通过抑制端粒酶活性，从而抑制癌变干细胞和祖细胞不可控制的增殖，导致癌变细胞的凋亡，具有改变疾病进程的活性。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2100000, "bbox": [[0.722, 0.495, 0.917, 0.505], [0.404, 0.512, 0.916, 0.521], [0.406, 0.528, 0.866, 0.538]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 27, "global_sentence_id": 37, "edu_l1_label": "IOS"}, {"txt": "该药此前于2024年6月获得美国FDA批准上市。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2100000, "bbox": [[0.866, 0.528, 0.916, 0.538], [0.405, 0.544, 0.696, 0.555]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 27, "global_sentence_id": 38, "edu_l1_label": "IOS"}, {"txt": "（来源：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2200000, "bbox": [[0.444, 0.561, 0.491, 0.571]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 28, "global_sentence_id": 39, "edu_l1_label": "IOS"}, {"txt": "Geron，太平洋证券研究院）", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2200000, "bbox": [[0.491, 0.561, 0.696, 0.572]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 28, "global_sentence_id": 40, "edu_l1_label": "IOS"}, {"txt": "公司要闻：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2300000, "bbox": [[0.438, 0.594, 0.509, 0.603]]}]}, "tags": ["title"], "label": "title2", "web_segment_id": 29, "global_sentence_id": 41, "edu_l1_label": "IOS"}, {"txt": "药明康德（603259)：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2400000, "bbox": [[0.438, 0.609, 0.582, 0.62]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 30, "global_sentence_id": 42, "edu_l1_label": "IOS"}, {"txt": "公司发布2024年年报，2024年公司实现营业收入392.41亿元，同比下降2.73%，归母净利润为94.50亿元，同比下降1.63%，扣非后归母净利润为99.88亿元，同比增长2.47％。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2400000, "bbox": [[0.582, 0.609, 0.916, 0.62], [0.405, 0.626, 0.917, 0.637], [0.405, 0.642, 0.843, 0.653]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 30, "global_sentence_id": 43, "edu_l1_label": "IOS"}, {"txt": "东阿阿胶（000423)：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2500000, "bbox": [[0.438, 0.659, 0.581, 0.669]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 31, "global_sentence_id": 44, "edu_l1_label": "IOS"}, {"txt": "公司发布2024年年报，2024年公司实现营业收入59.21亿元，同比增长25.57%，归母净利润为15.57亿元，同比增长35.29%，扣非后归母净利润为14.42亿元，同比增长33.17％。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2500000, "bbox": [[0.581, 0.659, 0.916, 0.668], [0.405, 0.675, 0.917, 0.685], [0.405, 0.691, 0.859, 0.702]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 31, "global_sentence_id": 45, "edu_l1_label": "IOS"}, {"txt": "药明康德（603259)：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2600000, "bbox": [[0.438, 0.707, 0.582, 0.718]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 32, "global_sentence_id": 46, "edu_l1_label": "IOS"}, {"txt": "公司发布公告，公司拟以自有资金及自筹资金回购公司股份，回购金额为10-20亿元，价格上限为92.05元／股，回购数量为10,863,661股，约占总股本的0.38%，回购用途为减少注册资本。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2600000, "bbox": [[0.582, 0.707, 0.917, 0.719], [0.406, 0.724, 0.917, 0.734], [0.405, 0.741, 0.916, 0.751]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 32, "global_sentence_id": 47, "edu_l1_label": "IOS"}, {"txt": "广生堂（300436)：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2700000, "bbox": [[0.438, 0.758, 0.566, 0.767]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 33, "global_sentence_id": 48, "edu_l1_label": "IOS"}, {"txt": "公司发布公告，子公司广生中霖于近日收到国家药监局下发的《受理通知书》，乙肝治疗创新药GST-HG131联合 GST-HG141针对乙肝经治患者的临床试验申请获得受理。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2700000, "bbox": [[0.566, 0.758, 0.916, 0.768], [0.406, 0.773, 0.917, 0.782], [0.405, 0.789, 0.721, 0.8]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 33, "global_sentence_id": 49, "edu_l1_label": "IOS"}, {"txt": "风险提示：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2800000, "bbox": [[0.437, 0.822, 0.509, 0.833]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 34, "global_sentence_id": 50, "edu_l1_label": "IOS"}, {"txt": "新药研发及上市不及预期；", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2800000, "bbox": [[0.509, 0.822, 0.705, 0.833]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 34, "global_sentence_id": 51, "edu_l1_label": "IOS"}, {"txt": "市场竞争加剧风险等。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2800000, "bbox": [[0.705, 0.822, 0.869, 0.833]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 34, "global_sentence_id": 52, "edu_l1_label": "IOS"}, {"txt": "分析师登记编号：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2900000, "bbox": [[0.104, 0.873, 0.212, 0.882]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 35, "global_sentence_id": 53, "edu_l1_label": "EDU_O"}, {"txt": "S1190524060001", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 2900000, "bbox": [[0.212, 0.873, 0.322, 0.881]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 35, "global_sentence_id": 54, "edu_l1_label": "EDU_O"}, {"txt": "footer", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3000000, "bbox": [[0.094, 0.963, 0.883, 0.976]]}]}, "tags": ["footer"], "label": "O", "web_segment_id": 36, "global_sentence_id": 55, "edu_l1_label": "EDU_O"}, {"txt": "header", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3000000, "bbox": [[0.711, 0.055, 0.784, 0.067]]}]}, "tags": ["header"], "label": "O", "web_segment_id": 1, "global_sentence_id": 56, "edu_l1_label": "EDU_O"}, {"txt": "header", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3000000, "bbox": [[0.096, 0.04, 0.283, 0.103]]}]}, "tags": ["header"], "label": "O", "web_segment_id": 2, "global_sentence_id": 57, "edu_l1_label": "EDU_O"}, {"txt": "header", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3000000, "bbox": [[0.371, 0.09, 0.784, 0.103]]}]}, "tags": ["header"], "label": "O", "web_segment_id": 3, "global_sentence_id": 58, "edu_l1_label": "EDU_O"}, {"txt": "投资评级说明", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3100000, "bbox": [[0.241, 0.194, 0.414, 0.215]]}]}, "tags": ["title"], "label": "title1", "web_segment_id": 4, "global_sentence_id": 59, "edu_l1_label": "EDU_O"}, {"txt": "1、行业评级", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3200000, "bbox": [[0.239, 0.225, 0.364, 0.24]]}]}, "tags": ["title"], "label": "title2", "web_segment_id": 5, "global_sentence_id": 60, "edu_l1_label": "IOS"}, {"txt": "看好：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3300000, "bbox": [[0.24, 0.252, 0.287, 0.265]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 6, "global_sentence_id": 61, "edu_l1_label": "EDU_O"}, {"txt": "预计未来6个月内，行业整体回报高于沪深300指数5％以上；", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3300000, "bbox": [[0.287, 0.252, 0.82, 0.266]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 6, "global_sentence_id": 62, "edu_l1_label": "EDU_O"}, {"txt": "中性：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3400000, "bbox": [[0.241, 0.277, 0.287, 0.29]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 7, "global_sentence_id": 63, "edu_l1_label": "EDU_O"}, {"txt": "预计未来6个月内，行业整体回报介于沪深300指数-5％与5％之间；", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3400000, "bbox": [[0.287, 0.277, 0.869, 0.29]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 7, "global_sentence_id": 64, "edu_l1_label": "EDU_O"}, {"txt": "看淡：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3500000, "bbox": [[0.241, 0.302, 0.287, 0.314]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 8, "global_sentence_id": 65, "edu_l1_label": "EDU_O"}, {"txt": "预计未来6个月内，行业整体回报低于沪深300指数5％以下。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3500000, "bbox": [[0.287, 0.302, 0.82, 0.315]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 8, "global_sentence_id": 66, "edu_l1_label": "EDU_O"}, {"txt": "2、公司评级", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3600000, "bbox": [[0.239, 0.328, 0.365, 0.342]]}]}, "tags": ["title"], "label": "title2", "web_segment_id": 9, "global_sentence_id": 67, "edu_l1_label": "IOS"}, {"txt": "买入：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3700000, "bbox": [[0.242, 0.354, 0.287, 0.366]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 10, "global_sentence_id": 68, "edu_l1_label": "IOS"}, {"txt": "预计未来6个月内，个股相对沪深300指数涨幅在15％以上；", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3700000, "bbox": [[0.287, 0.354, 0.811, 0.367]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 10, "global_sentence_id": 69, "edu_l1_label": "IOS"}, {"txt": "增持：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3800000, "bbox": [[0.24, 0.379, 0.287, 0.392]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 11, "global_sentence_id": 70, "edu_l1_label": "IOS"}, {"txt": "预计未来6个月内，个股相对沪深300指数涨幅介于5％与15％之间；", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3800000, "bbox": [[0.287, 0.379, 0.874, 0.392]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 11, "global_sentence_id": 71, "edu_l1_label": "IOS"}, {"txt": "持有：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3900000, "bbox": [[0.239, 0.403, 0.287, 0.416]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 12, "global_sentence_id": 72, "edu_l1_label": "EDU_O"}, {"txt": "预计未来6个月内，个股相对沪深300指数涨幅介于-5％与5％之间；", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 3900000, "bbox": [[0.287, 0.403, 0.869, 0.417]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 12, "global_sentence_id": 73, "edu_l1_label": "EDU_O"}, {"txt": "减持：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4000000, "bbox": [[0.241, 0.428, 0.287, 0.441]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 13, "global_sentence_id": 74, "edu_l1_label": "EDU_O"}, {"txt": "预计未来6个月内，个股相对沪深300指数涨幅介于-5％与-15％之间；", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4000000, "bbox": [[0.287, 0.428, 0.884, 0.442]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 13, "global_sentence_id": 75, "edu_l1_label": "EDU_O"}, {"txt": "卖出：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4100000, "bbox": [[0.241, 0.453, 0.287, 0.466]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 14, "global_sentence_id": 76, "edu_l1_label": "EDU_O"}, {"txt": "预计未来6个月内，个股相对沪深300指数涨幅低于-15％以下。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4100000, "bbox": [[0.287, 0.453, 0.835, 0.466]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 14, "global_sentence_id": 77, "edu_l1_label": "EDU_O"}, {"txt": "太平洋证券股份有限公司", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4200000, "bbox": [[0.241, 0.514, 0.561, 0.535]]}]}, "tags": ["title"], "label": "title1", "web_segment_id": 15, "global_sentence_id": 78, "edu_l1_label": "EDU_O"}, {"txt": "云南省昆明市盘龙区北京路926号同德广场写字楼31楼", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4300000, "bbox": [[0.242, 0.551, 0.719, 0.564]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 16, "global_sentence_id": 79, "edu_l1_label": "EDU_O"}, {"txt": "footer", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4400000, "bbox": [[0.069, 0.958, 0.868, 0.97]]}]}, "tags": ["footer"], "label": "O", "web_segment_id": 17, "global_sentence_id": 80, "edu_l1_label": "EDU_O"}, {"txt": "研究院", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4400000, "bbox": [[0.531, 0.176, 0.599, 0.192]]}]}, "tags": ["text"], "label": "O", "web_segment_id": 1, "global_sentence_id": 81, "edu_l1_label": "EDU_O"}, {"txt": "figure", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4400000, "bbox": [[0.143, 0.134, 0.472, 0.249]]}]}, "tags": ["figure"], "label": "figure", "web_segment_id": 2, "global_sentence_id": 82, "edu_l1_label": "EDU_O"}, {"txt": "中国北京 100044", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4400000, "bbox": [[0.531, 0.22, 0.677, 0.232]]}]}, "tags": ["text"], "label": "O", "web_segment_id": 3, "global_sentence_id": 83, "edu_l1_label": "EDU_O"}, {"txt": "北京市西城区北展北街九号", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4500000, "bbox": [[0.531, 0.26, 0.764, 0.274]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 4, "global_sentence_id": 84, "edu_l1_label": "EDU_O"}, {"txt": "华远·企业号D座", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4600000, "bbox": [[0.531, 0.3, 0.687, 0.315]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 5, "global_sentence_id": 85, "edu_l1_label": "EDU_O"}, {"txt": "figure", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4700000, "bbox": [[0.278, 0.263, 0.422, 0.371]]}]}, "tags": ["figure"], "label": "figure", "web_segment_id": 6, "global_sentence_id": 86, "edu_l1_label": "EDU_O"}, {"txt": "投诉电话：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4800000, "bbox": [[0.531, 0.341, 0.616, 0.354]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 7, "global_sentence_id": 87, "edu_l1_label": "EDU_O"}, {"txt": "95397", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4800000, "bbox": [[0.616, 0.341, 0.687, 0.354]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 7, "global_sentence_id": 88, "edu_l1_label": "EDU_O"}, {"txt": "投诉邮箱：", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4900000, "bbox": [[0.531, 0.38, 0.616, 0.394]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 8, "global_sentence_id": 89, "edu_l1_label": "EDU_O"}, {"txt": "kefu@tpyzq.com", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 4900000, "bbox": [[0.616, 0.38, 0.775, 0.393]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 8, "global_sentence_id": 90, "edu_l1_label": "EDU_O"}, {"txt": "免责声明", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 5000000, "bbox": [[0.147, 0.522, 0.237, 0.54]]}]}, "tags": ["title"], "label": "title1", "web_segment_id": 9, "global_sentence_id": 91, "edu_l1_label": "EDU_O"}, {"txt": "太平洋证券股份有限公司（以下简称“我公司”或“太平洋证券”）具备中国证券监督管理委员会核准的证券投资咨询业务资格。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 5100000, "bbox": [[0.18, 0.556, 0.891, 0.569], [0.146, 0.582, 0.393, 0.594]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 10, "global_sentence_id": 92, "edu_l1_label": "IOS"}, {"txt": "本报告仅向与太平洋证券签署服务协议的签约客户发布，为太平洋证券签约客户的专属研究产品，若您并非太平洋证券签约客户，请取消接收、订阅或使用本报告中的任何信息；", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 5200000, "bbox": [[0.18, 0.608, 0.882, 0.619], [0.147, 0.634, 0.77, 0.646]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 11, "global_sentence_id": 93, "edu_l1_label": "IOS"}, {"txt": "太平洋证券不会因接收人收到、阅读或关注媒体推送本报告中的内容而视其为太平洋证券的客户。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 5200000, "bbox": [[0.77, 0.634, 0.9, 0.647], [0.146, 0.66, 0.753, 0.672]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 11, "global_sentence_id": 94, "edu_l1_label": "IOS"}, {"txt": "在任何情况下，本报告中的信息或所表述的意见并不构成对任何机构和个人的投资建议，投资者应自主作出投资决策并自行承担投资风险，任何形式的分享证券投资收益或者分担证券投资损失的书面或口头承诺均为无效。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 5200000, "bbox": [[0.753, 0.66, 0.901, 0.673], [0.146, 0.685, 0.9, 0.698], [0.148, 0.711, 0.883, 0.723], [0.146, 0.736, 0.171, 0.749]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 11, "global_sentence_id": 95, "edu_l1_label": "IOS"}, {"txt": "本报告信息均来源于公开资料，我公司对这些信息的准确性和完整性不作任何保证。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 5300000, "bbox": [[0.18, 0.763, 0.805, 0.775]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 12, "global_sentence_id": 96, "edu_l1_label": "IOS"}, {"txt": "负责准备本报告以及撰写本报告的所有研究分析师或工作人员在此保证，本研究报告中关于任何发行商或证券所发表的观点均如实反映研究人员的个人观点。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 5300000, "bbox": [[0.805, 0.763, 0.9, 0.775], [0.146, 0.789, 0.9, 0.801], [0.146, 0.814, 0.481, 0.826]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 12, "global_sentence_id": 97, "edu_l1_label": "IOS"}, {"txt": "报告中的内容和意见仅供参考，并不构成对所述证券买卖的出价或询价。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 5300000, "bbox": [[0.481, 0.814, 0.9, 0.827], [0.146, 0.84, 0.273, 0.852]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 12, "global_sentence_id": 98, "edu_l1_label": "IOS"}, {"txt": "我公司及其雇员对使用本报告及其内容所引发的任何直接或间接损失概不负责。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 5300000, "bbox": [[0.273, 0.84, 0.875, 0.852]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 12, "global_sentence_id": 99, "edu_l1_label": "IOS"}, {"txt": "我公司或关联机构可能会持有报告中所提到的公司所发行的证券头寸并进行交易，还可能为这些公司提供或争取提供投资银行业务服务。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 5300000, "bbox": [[0.875, 0.84, 0.9, 0.852], [0.147, 0.866, 0.9, 0.879], [0.146, 0.891, 0.394, 0.903]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 12, "global_sentence_id": 100, "edu_l1_label": "IOS"}, {"txt": "本报告版权归太平洋证券股份有限公司所有，未经书面许可任何机构和个人不得以任何形式翻版、复制、刊登。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 5300000, "bbox": [[0.394, 0.891, 0.9, 0.903], [0.146, 0.917, 0.482, 0.929]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 12, "global_sentence_id": 101, "edu_l1_label": "IOS"}, {"txt": "任何人使用本报告，视为同意以上声明。", "language": "chinese", "position": {"pdf_position": [{"page_number": 0, "shape": [1650, 1275], "position_id": 5300000, "bbox": [[0.482, 0.917, 0.788, 0.929]]}]}, "tags": ["text"], "label": "content", "web_segment_id": 12, "global_sentence_id": 102, "edu_l1_label": "IOS"}], "type": "PDF"}
# 太平洋医药日报（20250317):Rytelo在欧盟获批上市
## 报告摘要
### 市场表现：
### 行业要闻：
### 公司要闻：
### 风险提示：新药研发及上市不及预期；市场竞争加剧风险等。
